Company's seventh sustainability report
highlights progress in product quality & safety, environmental
impact improvements and diversity, equity and inclusion
initiatives
WARSAW,
Ind., May 2, 2023 /PRNewswire/ -- Zimmer Biomet
Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology
leader, today announced that it published its 2022 Sustainability
Report. The report provides an overview of the company's
environmental, social, governance program, progress and
accomplishments. Further, the report outlines the company's new
commitment to achieve carbon neutrality for Scope 1 and 2 emissions
at all manufacturing sites by 2050, discloses Zimmer Biomet EEO-1
data and aligns with the Sustainability Accounting Standards Board
(SASB) framework.
Keri P. Mattox, Chief
Communications and Administration Officer, Zimmer Biomet commented,
"We are proud to release our Sustainability Report, which features
our progress in developing a more sustainable business globally and
our commitment to ever-higher standards of patient safety and
quality in our products and services, and to world-class integrity
and ethical business practices. The report showcases Zimmer
Biomet's commitment to deliver on our mission – to alleviate pain
and improve the quality of life for people around the world."
The report highlights Zimmer Biomet's accomplishments,
including:
- Achieved our 2022 milestones towards Zimmer Biomet's 2026
Diversity, Equity and Inclusion representation goals for women
globally, and people of color in the U.S. at the director-level and
above, while also publicly disclosing EEO-1 data for the first
time
- Launched our Best & Preferred Place to Work strategy
focused on shared purpose, deeper connections, holistic well-being
and professional and personal growth
- Continued progress on our quality management programs and
performance, demonstrating a 10-fold decrease in product recalls
since 2016 and again maintaining fewer than 10 product recalls in
2022
- Earned a Leadership Level grade of A- from the Carbon
Disclosure Project
- Continued progress on our Science Based Target
initiative-approved goal to reduce our operational (Scope 1 + 2)
emissions 50% and purchased goods and services (Scope 3) emissions
15% by 2030
- Upgraded to 'AA' ESG rating by MSCI in February 2023
Find the full report on
https://investor.zimmerbiomet.com/corporate-governance/sustainability-report
About the Company
Zimmer Biomet is a global medical technology leader
with a comprehensive portfolio designed to maximize mobility and
improve health. We seamlessly transform the patient experience
through our innovative products and suite of integrated digital and
robotic technologies that leverage data, data analytics and
artificial intelligence.
With 90+ years of trusted leadership and proven expertise,
Zimmer Biomet is positioned to deliver the highest quality
solutions to patients and providers. Our legacy continues to
come to life today through our progressive culture of evolution and
innovation.
For more information about our product portfolio, our operations
in 25+ countries and sales in 100+ countries or about joining our
team, visit www.zimmerbiomet.com or follow Zimmer Biomet
on Twitter at www.twitter.com/zimmerbiomet.
Cautionary Statement Regarding Forward-Looking
Statements
This news release contains forward-looking statements within
the meaning of the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995. Forward-looking statements include,
but are not limited to, statements concerning Zimmer Biomet's
expectations, plans, prospects, and product and service offerings,
including new product launches and potential clinical successes.
Such statements are based upon the current beliefs and expectations
of management and are subject to significant risks, uncertainties
and changes in circumstances that could cause actual outcomes and
results to differ materially. For a list and description of some of
such risks and uncertainties, see Zimmer Biomet's periodic reports
filed with the U.S. Securities and Exchange Commission
(SEC). These factors should not be construed as exhaustive and
should be read in conjunction with the other cautionary statements
that are included in Zimmer Biomet's filings with the SEC.
Forward-looking statements speak only as of the date they are made,
and Zimmer Biomet disclaims any intention or obligation to update
or revise any forward-looking statements, whether as a result of
new information, future events or otherwise. Readers of this news
release are cautioned not to rely on these forward-looking
statements, since there can be no assurance that these
forward-looking statements will prove to be accurate. This
cautionary statement is applicable to all forward-looking
statements contained in this news release.
###
Media
|
Investors
|
Meredith
Weissman
|
Zach Weiner
|
(703)
346-3127
|
(908)
591-6955
|
meredith.weissman@zimmerbiomet.com
|
zach.weiner@zimmerbiomet.com
|
|
|
Heather
Zoumas-Lubeski
|
|
(445)
248-0577
|
|
heather.zoumaslubeski@zimmerbiomet.com
|
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/zimmer-biomet-publishes-2022-sustainability-report-301813018.html
SOURCE Zimmer Biomet Holdings, Inc.